Index by author

September 01, 2012; Volume 79,Issue 9

  1. Thota, Swapna

    1. Immune thrombocytopenia in adults: An update
      Swapna Thota, MD, Gaurav Kistangari, MD, Hamed Daw, MD and Timothy Spiro, MD
      Cleveland Clinic Journal of Medicine September 2012, 79 (9) 641-650; DOI: https://doi.org/10.3949/ccjm.79a.11027

      Management has changed in the last decade, with new drugs and with increased awareness of treatment side effects.

  2. Udeh, Belinda L.

    1. The apples and oranges of cost-effectiveness: A rejoinder
      Chiedozie I. Udeh, MD, MHLTHEC and Belinda L. Udeh, PhD, MPH
      Cleveland Clinic Journal of Medicine September 2012, 79 (9) 608-610; DOI: https://doi.org/10.3949/ccjm.79a.12123

      A recent CCJM commentary used straw men to indict cost-effectiveness research.

  3. Udeh, Chiedozie I.

    1. The apples and oranges of cost-effectiveness: A rejoinder
      Chiedozie I. Udeh, MD, MHLTHEC and Belinda L. Udeh, PhD, MPH
      Cleveland Clinic Journal of Medicine September 2012, 79 (9) 608-610; DOI: https://doi.org/10.3949/ccjm.79a.12123

      A recent CCJM commentary used straw men to indict cost-effectiveness research.

  4. Wattanakit, Keattiyoat

    1. Using the ankle-brachial index to diagnose peripheral artery disease and assess cardiovascular risk
      Using the ankle-brachial index to diagnose peripheral artery disease and assess cardiovascular risk
      Esther S. H. Kim, MD, MPH, Keattiyoat Wattanakit, MD, MPH and Heather L. Gornik, MD, MHS
      Cleveland Clinic Journal of Medicine September 2012, 79 (9) 651-661; DOI: https://doi.org/10.3949/ccjm.79a.11154

      The authors seek to convince you to measure the ankle-brachial index in any patient you suspect may have peripheral artery disease, whether or not they have symptoms.

  5. Wilson Tang, W. H.

    1. The role of aldosterone receptor antagonists in the management of heart failure: An update
      Vijaiganesh Nagarajan, MD, Mohammed Chamsi-Pasha, MD and W. H. Wilson Tang, MD
      Cleveland Clinic Journal of Medicine September 2012, 79 (9) 631-639; DOI: https://doi.org/10.3949/ccjm.79a.12014

      Spironolactone (Aldactone) and eplerenone (Inspra) are now part of standard therapy. Still, they must be used cautiously, as they can cause hyperkalemia.

« Previous (Pages : 1 2 3 ... 3)next »
Back to top

In this issue